Bone Marrow TransplantationBone MarrowBone Marrow CellsTissue DonorsHistocompatibility TestingTransplantation, HomologousGraft vs Host DiseaseHistocompatibilityBone and BonesTissue and Organ ProcurementTransplantation, AutologousHLA AntigensWhole-Body IrradiationAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationTransplantation ConditioningHematopoietic Stem CellsBone Marrow DiseasesGraft SurvivalBone Marrow PurgingBone Marrow ExaminationTransplantation ChimeraBone RemodelingLiver TransplantationBone Marrow NeoplasmsBusulfanHematopoiesisRegistriesMice, Inbred C57BLCyclophosphamideLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsGraft vs Host ReactionTransplantation, IsogeneicRecurrenceBone DensityRadiation ChimeraLeukocyte TransfusionTreatment OutcomeHematologic NeoplasmsCombined Modality TherapyLiving DonorsGraft RejectionLeukemia, Myeloid, AcuteKidney TransplantationImmunosuppressionColony-Forming Units AssayBone ResorptionSurvival AnalysisBlood DonorsAcute DiseaseRetrospective StudiesT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaCell DifferentiationRemission InductionImmunosuppressive AgentsLeukemia, MyeloidBone NeoplasmsFlow CytometryHepatic Veno-Occlusive DiseaseTransplantation ImmunologyLymphocyte DepletionSurvival RateLymphoma, Non-HodgkinStem Cell TransplantationMyelodysplastic SyndromesCells, CulturedChimeraMice, Inbred BALB CAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalSevere Combined ImmunodeficiencySpleenHeart TransplantationPancytopeniaHematologic DiseasesCord Blood Stem Cell TransplantationCell ProliferationFollow-Up StudiesBone DevelopmentBone DiseasesGranulocyte Colony-Stimulating FactorMultiple MyelomaLeukocyte CountBreast NeoplasmsStromal CellsAntigens, CD34Actuarial AnalysisCyclosporinePrognosisAntineoplastic AgentsLymphocyte TransfusionGranulocytesMice, KnockoutAntibodies, MonoclonalCell DivisionLung TransplantationNuclear Family